A Prospective Observational Study of Foam Sclerotherapy .
A Prospective Observational Study of Foam Sclerotherapy for the Treatment of Symptomatic Kidney or Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney and Liver Disease.
Mayo Clinic
100 participants
Nov 6, 2017
OBSERVATIONAL
Conditions
Summary
An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).
Eligibility
Inclusion Criteria4
- Age ≥18 years
- Clinical diagnosis of ADPKD or ADPLD
- large, non-exophytic liver or kidney cyst
- Compressive symptoms from dominant cyst
Exclusion Criteria7
- Age \<18 years
- Absence of ADPKD or ADPLD
- Largest cyst \<4cm in all 3 dimensions or largest cyst volume \<400cc
- \>3 large, non-exophytic liver or kidney cyst(s) ≥4cm in all 3 dimensions (cyst volume ≥400cc)
- Unwilling to comply with study follow-up protocol to 12 ± 1months post-FS
- Lacking capacity to provide informed consent to FS of liver or kidney cysts
- Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04111692